Rett Syndrome Europe

What Rett Syndrome Europe does

Rett Syndrome Europe (RSE) is a European non-profit association that represents people with Rett syndrome and their families across 25 member countries. It coordinates a federation of national Rett syndrome associations — covering markets such as Austria, Belgium, France, Germany, Italy, Spain, the Nordics, the Baltics, the Balkans, and the UK — alongside clinicians and researchers, with the stated purpose of improving care, advancing research, and raising awareness of the condition.

RSE's core "products" are programmatic rather than commercial. The organization runs three flagship initiatives: rettX, a pan-European, secure, family-driven patient registry consolidating Rett syndrome data across countries; Rett Forum 2026, the first pan-European expert convening on standards of care, scheduled for October 2026 in Madrid with 50–60 experts from 30+ countries across six thematic working groups; and an independent Scientific Advisory Board of 15 leading clinicians and researchers. It also maintains a multilingual content library — the Rett Syndrome Communication Guidelines, the Rett Resource comprehensive care guide (available in 11 languages), and a curated list of 19 books about Rett syndrome — distributed through its website and the national-association network.

RSE's business model is donation-based. The organization is entirely volunteer-led, so every donated euro is stated to flow directly to programmes. No paid services, membership fees, or commercial products are offered; donations are accepted via PayPal and described as tax-deductible in many EU countries. Revenue, headcount, and financial filings are not disclosed. Distribution is achieved through the website (rettsyndrome.eu), social channels (Facebook, Instagram, LinkedIn), newsletters, and the 25 national member associations that act as local touchpoints. RSE also operates under formal GDPR compliance, with a designated Data Protection Officer ([email protected]).

Name

Rett Syndrome Europe

Legal name

Rett Syndrome Europe

Website

https://rettsyndrome.eu

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

1–10 employees

Short description

Rett Syndrome Europe is a volunteer-led European non-profit association representing people with Rett syndrome and their families across 25 member countries, coordinating the rettX patient registry, Rett Forum 2026 expert convening, and a 15-member Scientific Advisory Board.

Ownership category

akta.pro rank

Product category

Patient Advocacy / Rare Disease Non-Profit

NAICS

Services for the Elderly and Persons with Disabilities (62412), Individual and Family Services (6241)

SIC

Services-Social Services (8300), Services-Membership Organizations (8600)

akta.pro primary industry

Family Care Navigation & Care Coordination Platforms (multi-member care plans, referrals) (HLALAHAL)

akta.pro secondary industry

Reentry & Justice-Involved Support Services (BPAGAEAN)

Keywords

• Rare disease advocacy
• Patient registry services
• Neurological disorder support
• Family support resources
• Patient association network

GTM type

B2C

Offering type

Services

Cost components

Operations, Marketing or Sales, Infrastructure, Others

Revenue model

1. Donations: RSE is funded through donations from individuals, families, and supporters. The organization states it is entirely volunteer-led, meaning every donation euro goes directly to programs supporting families and research.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

Rett Syndrome Europe is a pan-European non-profit association that supports families affected by Rett syndrome and advances research on the condition. Its core offerings include coordinating a network of 25 national member associations, operating the rettX pan-European patient registry, convening experts through Rett Forum 2026 to draft European consensus-based standards of care, and providing multilingual family resources (Rett Communication Guidelines, Rett Resource in 11 languages, curated literature).

Product overview

Rett Syndrome Europe operates as a non-profit association that coordinates three flagship programs alongside its member associations: (1) rettX, the pan-European patient registry enabling families to contribute data for research; (2) Rett Forum 2026, a pan-European expert convening on standards of care; and (3) the Scientific Advisory Board providing independent clinical guidance. The organization also provides practical family resources including the Rett Syndrome Communication Guidelines handbook, the Rett Resource comprehensive care guide available in 11 languages, and a curated literature list of books about Rett syndrome.

Differentiator

Problem solved

Functional benefit

Products and services

• rettX (European Patient Registry) A secure, family-driven pan-European patient registry where families affected by Rett syndrome contribute data to advance care, research, and treatments across all participating countries in a single secure platform.
• Rett Forum 2026 (European Edition) The first pan-European expert convening on standards of care for Rett syndrome, bringing together 50-60 experts from 30+ countries across six thematic working groups to draft the first European consensus-based standards. Scheduled for October 2026 in Madrid.
• Scientific Advisory Board An independent group of 15 leading clinicians and researchers from across Europe who advise RSE, review emerging evidence, and support member associations in interpreting new Rett syndrome research.
• Rett Syndrome Communication Guidelines Practical recommendations for caregivers and communication professionals to support communication development for people with Rett syndrome. Covers practical tools to improve quality of life and enable more effective expression.
• Rett Resource A comprehensive practical reference for families, caregivers and clinicians on the medical and day-to-day management of Rett syndrome. Covers bone health, drooling, depression, epilepsy, GI issues, genetics, nutrition, scoliosis, sleep, stereotypies, and common therapies. Available in 11 languages.
• Books about Rett Syndrome A curated reading list spanning three decades featuring 19 handbooks for families, doctoral research, clinical references, and practical guides for everyone supporting people with Rett syndrome. Most books are written in plain language families can read.

Quantifiable outcome

• Positive CHMP opinion for Daybu (trofinetide) achieved, representing the first medicine specifically approved for Rett syndrome in Europe
• +1 more outcomes

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Three partnerships are on record, tiered flagship and core.

• rettX (European Patient Registry)flagshipOthersrettX is the pan-European patient registry led by Rett Syndrome Europe where families help advance care, research and treatments for Rett syndrome across every country in one secure place.
• Scientific Advisory BoardcoreOthersAn independent group of 15 leading clinicians and researchers from across Europe who advise RSE, review emerging evidence, and support member associations in interpreting new research.
• National Member Associations (25 countries)flagshipOthersRSE works alongside national Rett syndrome associations across Europe including Austria, Belgium, Croatia, Cyprus, Czech Republic, Denmark, Finland, France, Germany (2), Greece (2), Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Macedonia, Malta, Montenegro, Netherlands, Norway, Poland, Portugal, Russia, Serbia, Slovakia, Slovenia, Spain (3), Sweden, Switzerland, Turkey, Ukraine, and United Kingdom (2).

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Orphanet: Orphanet is a pan-European reference portal for rare diseases and orphan drugs, providing disease classifications, epidemiology data, and resource directories. It is comparable to RSE in pan-European rare-disease focus and information provision role, though Orphanet is an academic/database consortium rather than a patient-led advocacy federation.
• EURORDIS - Rare Diseases Europe: EURORDIS is a pan-European non-profit alliance of over 1,000 rare disease patient organizations, making it the most directly comparable peer to RSE in scope, federation governance model, and continental advocacy focus. RSE effectively operates as a disease-specific counterpart within the broader rare-disease advocacy ecosystem that EURORDIS convenes.
• Rett Syndrome Research Trust: RSRT is the leading US-based non-profit funding Rett syndrome research, with a comparable mission (advancing treatments and cure for Rett syndrome) through scientific funding, family engagement, and research coordination. It is the closest disease-specific peer, differing mainly in geography (US vs Europe) and funding model (research grants vs advocacy/family support).
• International Rett Syndrome Foundation: IRSF is the oldest and largest US-based Rett syndrome non-profit, providing family support, research funding, and maintaining a Rett syndrome patient registry. It is a direct disease-specific peer comparable in core mission and overlapping programs such as patient registries and family resources.

Broad incumbents

• Muscular Dystrophy Association: MDA is a large US-based voluntary health organization funding neuromuscular disease research, care, and advocacy across a broad condition portfolio. It is comparable to RSE as a patient advocacy nonprofit supporting rare neurological conditions, but MDA's broader scope, paid-staff operating model, and US-centric operations make it a broad incumbent.
• ALS Association: The ALS Association is a major US-based nonprofit driving amyotrophic lateral sclerosis research, care services, and policy advocacy. It is comparable to RSE as a rare neurological disease patient advocacy nonprofit with research funding, care guidelines, and policy engagement, but operates at substantially larger scale, broader resources, and US-centric scope.
• NORD - National Organization for Rare Disorders: NORD is the largest US-based umbrella organization for rare diseases, representing ~300 patient organizations. It is comparable to RSE as a federation-style rare-disease advocacy nonprofit but operates at significantly larger scale, broader disease scope, and US-centric footprint, making it a broad incumbent rather than a direct peer.
• Cystic Fibrosis Foundation: CFF is the leading US-based nonprofit driving cystic fibrosis research and care, notable for pioneering patient registry models and substantial research funding. It is comparable to RSE in rare-disease advocacy, registry infrastructure, and treatment access focus, though at substantially larger scale, broader resources, and broader research-funding footprint.

Regional players

• European Brain Council: EBC is a pan-European non-profit coordinating neurological disorder patient organizations, clinicians, and researchers at the EU policy level. It is comparable to RSE in pan-European neurological advocacy mission and federation-style governance, though EBC operates as an umbrella across many neurological conditions rather than a single disease.

Others

• European Patients' Academy (EUPATI): EUPATI is a pan-European initiative providing patient education and advocacy training across disease areas. It is thematically related to RSE as both work to strengthen patient advocacy capability in Europe, though EUPATI focuses on training and education rather than single-disease research, registry, and family support.

Market position

Strengths4 records

Weaknesses3 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/Rett-Syndrome-Europe-232940826831244
• LinkedInlinkedin.com/company/retteurope
• Instagraminstagram.com/retteurope

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rett Syndrome Europe